BioArctic: New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD congress

AI Briefing

• – New data on lecanemab treatment presented at the 2026 AD/PD congress.
• – BioArctic's partner Eisai presented the findings.
• – Details on the treatment's long-term effects unclear.